热门资讯> 正文
周日报道，分子合作伙伴和Orano Med在SNMMI 2025上展示了有关间皮素靶向放射性DARPin MP 0726的临床前数据
2025-06-23 15:10
- Return Stacked Bonds & Managed Futures ETF Grizzle Growth ETF(DARP) 0
- MP Materials Corporation Ordinary Shares - Class A(MP) 0
- SharkNinja(SN) 0
- MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med
- Promising tumor accumulation and attractive biodistribution shown in vivo, selective binding to membrane-bound MSLN with positive tumor to kidney ratio
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
